OneMedNet

What OneMedNet does

OneMedNet Corporation (NASDAQ: ONMD) operates an AI-driven Real-World Data (RWD) platform that provides life sciences organizations, medical AI developers, and other regulated industries with regulatory-grade, multimodal clinical data sourced from a network of more than 2,300 healthcare partner sites. As of mid-2026 the network spans more than 90 million patient journeys, 270 million studies, 131 million clinical exams, and over 5 billion administrative claims, with 20+ years of historical depth and prospective real-time data feeds. The company is headquartered in Eden Prairie, Minnesota, employs between 11 and 50 people, and incorporated in Delaware.

The company's core product is the iRWD™ platform, built natively on Palantir Foundry and Palantir's Artificial Intelligence Platform (AIP) under a multi-year partnership. The platform combines LLM-powered conversational (agentic) search, automated de-identification that blends symbolic/statistical AI with LLMs and SLMs under human-in-the-loop quality validation, multimodal integration of medical imaging (DICOM), EHR, laboratory, EEG/ECG, and claims data, and tokenization via Datavant for linkage to approximately 47 million tokenized patients. AI is deployed both internally for cohort discovery (reducing feasibility timelines from weeks to minutes) and externally by enabling customers such as mlHealth 360 to obtain FDA 510(k) clearance for AI diagnostic software using OneMedNet's curated datasets.

OneMedNet generates revenue through a mix of multi-year subscription data licenses, subscription search platform access (Palantir Agentic Search), curated bespoke datasets priced per project, pre-curated specialty datasets for oncology, neurology, cardiology and rare diseases, and freemium published datasets on AWS Marketplace. The company has transitioned from project-based engagements to recurring subscription contracts and sells through direct enterprise field sales supplemented by five data marketplace channels (AWS Marketplace, Amazon Data Exchange, Datavant, HealthVerity, Bayer Data Marketplace) and the Palantir ecosystem. Primary customer segments are life sciences organizations (pharmaceutical, biotech, medical device) and AI developers, with secondary exposure to academia, finance, retail, and telecom for de-identified test and analytics data.

Name

OneMedNet

Legal name

OneMedNet Corporation

Website

https://onemednet.com

Company type

Public

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

OneMedNet operates an AI-driven Real-World Data platform, providing regulatory-grade multimodal clinical data (medical imaging, EHR, labs, EEG) to life sciences organizations and medical AI developers. Built on Palantir Foundry, the platform spans 2,300+ healthcare sites with 90M+ patient journeys.

Ownership category

akta.pro rank

Product category

Healthcare Real-World Data Platform

NAICS

Software Publishers (5132), Custom Computer Programming Services (541511), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)

akta.pro primary industry

Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL)

akta.pro secondary industries

Enterprise Integration Engines & Interface Management (HL7 v2/X12/API) (HLACABAC), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

Keywords

• Real-world data platform
• Healthcare data analytics
• De-identified medical imaging
• Longitudinal patient data
• Regulatory-grade RWD

Headquarters

HQ city

Eden Prairie

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Subscription Data License: Multi-year subscription agreements providing continuous access to de-identified longitudinal patient journeys, ongoing cohort refresh, and model retraining support. Represents the company's strategic shift toward recurring revenue model with higher enterprise value through continuous, real-time data access.
2. Subscription Search Platform: Palantir Agentic Search (LLM) subscription for data discovery and analytics, enabling cohort feasibility analysis with compressed timelines. Positioned at higher price points delivering greater enterprise value through AI-powered discovery workflows.
3. Curated Bespoke Data Sets: Regulatory-grade, multimodal datasets tailored for AI model development, drug, device and therapeutics development, validation, and regulatory submission. Project-based engagements with custom pricing based on scope.
4. Pre-Curated Specialty Datasets: High-value, pre-assembled regulatory-grade datasets focused on key therapeutic areas including oncology, neurology, cardiology, and rare diseases. Available through AWS Marketplace for immediate access.
5. AWS Marketplace Published Datasets: Free and subscription-based published datasets hosted on AWS Marketplace including breast cancer, cardiovascular, lung cancer, melanoma, orthopedic, osteoporosis, pancreatic cancer, prostate cancer, and stroke datasets.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

OneMedNet provides an AI-driven Real-World Data (iRWD™) platform built on the Palantir Foundry ecosystem that delivers regulatory-grade, de-identified multimodal clinical data — including medical imaging, electronic health records, laboratory results, EEG/ECG, and longitudinal patient records — to life sciences organizations, medical AI developers, and other data-intensive enterprises. Its offerings span subscription-based data licensing with live data feeds, curated bespoke datasets for AI model development and regulatory submissions, and free sample published datasets distributed through AWS Marketplace.

Product overview

OneMedNet offers a unified platform architecture centered on its iRWD™ (imaging Real-World Data) Platform, which serves as the core product connecting life sciences organizations to curated, regulatory-grade multimodal Real-World Data. The platform is powered by Palantir Foundry and encompasses multiple integrated modules: Real-Time Data for longitudinal clinical and imaging data streams, Data Masking for AI-driven de-identification, Subscription Data for ongoing access to specialty disease datasets (oncology, autoimmune), and Published Datasets for free sample datasets on AWS Marketplace. Key capabilities include Palantir Agentic Search (LLM-powered conversational search) and Live Data Feeds for continuous data streaming. The company also provides curated bespoke datasets and pre-curated specialty datasets tailored for AI model development, drug/device development, and regulatory submissions.

Differentiator

Problem solved

Functional benefit

Brands

• BEAM: A peer-to-peer (P2P) network for securely sharing medical images between hospitals, clinics, healthcare providers and patients. Originally focused on image exchange, now largely sunset in favor of the iRWD platform.
• iRWD
• iRWD Network

Products and services

• iRWD™ Platform OneMedNet's flagship AI-driven Real-World Data platform powered by Palantir Foundry, providing searchable access to regulatory-grade, multimodal clinical data including medical imaging, EHR, and longitudinal patient records across a network of 2,300+ healthcare provider sites. Target users: life sciences organizations, medical AI developers, and pharmaceutical/biotech companies.
• Real-Time Data Longitudinal clinical and imaging data access enabling continuous updates on cohorts with prospective and real-time data streams. Provides living, breathing data to build richer real-world evidence over years of follow-up. For life sciences, pharma, and AI developers needing ongoing cohort data.
• Data Masking

Quantifiable outcome

• 329% year-over-year revenue increase (2024 to 2025)
• +6 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature7 records

Partnerships

Ten partnerships are on record, tiered strategic and core.

• Onco-Innovations Limited / Inka HealthstrategicStrategic or Co-development Partner · 1 April 2026Collaboration granting Inka Health access to iRWD platform for U.S. real-world oncology data. Supports development of Onco-Innovations' PNKP Inhibitor Technology targeting PTEN/SHP1-deficient cancers, including patient responder identification and indication expansion beyond metastatic colorectal cancer.
• NavidencestrategicTechnology or Integration · 18 March 2026Strategic collaboration integrating Navidence's Computable Operational Definitions (CODefs) with the iRWD platform. Enables pharmaceutical companies to transform RWD into actionable evidence for regulatory submissions, post-market surveillance, and AI model training. Targets the RWD market valued at approximately $1.88 billion in 2025.
• ViuHealthcoreStrategic or Co-development Partner · 26 February 2026Strategic partnership integrating ViuHealth's longitudinal autoimmune disease data into the iRWD platform. ViuHealth provides ongoing patient journey data including treatment adherence, flares, and outcomes to support pharma partners in drug discovery, HEOR initiatives, and regulatory-aligned use cases. Targets the projected $166 billion+ autoimmune therapeutics market.
• Risorius Co., Ltd.coreStrategic or Co-development Partner · 24 February 2026Strategic data licensing agreement for large-scale EEG and polysomnography waveform data paired with longitudinal clinical data. Supports Risorius's development of EEG-based digital biomarkers and AI Co-Scientist platform for CNS research. Data delivery underway over a three-month project period representing millions in incremental recurring revenue.
• Palantir TechnologiescoreTechnology or Integration · 6 October 2025Multi-year partnership under which Palantir's Artificial Intelligence Platform (AIP) serves as infrastructure for OneMedNet's iRWD™ near-real-time healthcare data network. The platform spans over 1,750 provider sites with access to billions of administrative claims and 131 million clinical exams across oncology, cardiology, and rare diseases. Deal strengthens Palantir's healthcare AI footprint while enabling OneMedNet to deliver AI-powered search and data analytics capabilities.
• DatavantcoreTechnology or IntegrationTokenization partnership enabling access to approximately 47 million tokenized patients. Datavant's tokenization allows seamless linkage to complementary datasets including genomics, claims, and mortality data for deeper longitudinal insights without exposing patient identities.
• Amazon Web Services (AWS)strategicTechnology or IntegrationAWS Marketplace hosting of published datasets for breast cancer, cardiovascular, lung cancer, melanoma, and other disease categories. Enables direct customer access to sample and subscription datasets through AWS infrastructure.
• Amazon Data ExchangestrategicChannel Partner/ Reseller/ DistributorData marketplace partnership for distribution of regulatory-grade RWD datasets to customers through Amazon's data exchange platform.
• HealthVeritystrategicChannel Partner/ Reseller/ DistributorData marketplace partnership enabling distribution of healthcare data through HealthVerity's platform for real-world evidence and research applications.
• Bayer Data MarketplacestrategicChannel Partner/ Reseller/ DistributorPartnership with Bayer's data marketplace for distribution of RWD datasets to pharmaceutical and life sciences customers.

Scale indicators18 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Tempus AI: Tempus AI provides AI-enabled precision medicine and a large multimodal library of clinical and molecular real-world data to life sciences and providers. It competes most directly with OneMedNet in regulatory-grade, imaging-rich RWD for pharma R&D, AI training, and FDA submissions.
• Flatiron Health: Flatiron Health (a Roche company) aggregates de-identified oncology EHR data and offers longitudinal real-world evidence to life sciences. It is a direct competitor to OneMedNet's oncology-focused RWD, with comparable regulatory-grade positioning and similar pharma customers.
• Komodo Health: Komodo Health operates a healthcare map and RWD platform linking de-identified patient journeys for pharma, biotech, and medical device companies. It competes with OneMedNet in longitudinal RWD, AI training data, and analytics for life sciences commercial and clinical use cases.
• TriNetX: TriNetX operates a federated real-world data network of academic medical centers and hospitals for clinical trial feasibility and real-world evidence. It is comparable to OneMedNet's hospital network model and pharma subscription economics.

Broad incumbents

• IQVIA: IQVIA is the largest clinical and real-world data provider, offering E360 Real-World Data plus technology, CRO, and commercial services to pharma. It is a broad incumbent that competes with OneMedNet across RWD, evidence generation, and trial enablement for life sciences.

Emerging players

• Datavant: Datavant provides tokenization and connectivity that links de-identified patient data across providers, payers, and data owners. It is both a OneMedNet partner (47M tokenized patients) and an emerging competitor in healthcare data linkage and exchange.
• HealthVerity: HealthVerity provides the HEALTHCARE DATA EXCHANGE and privacy-protecting tokenization for assembling de-identified patient journeys across claims, EHR, and labs. It is a marketplace partner and a partial competitor in privacy-preserving healthcare data assembly.
• Aetion: Aetion delivers a real-world evidence platform used by regulators and pharma for regulatory-grade RWE analyses. It is comparable to OneMedNet for life sciences RWE use cases, with overlap in regulatory submission support.

Others

• Palantir Technologies: Palantir is both a core technology partner (Foundry/AIP powers iRWD) and an adjacent enabler in healthcare AI and data integration. It is relevant because OneMedNet's product differentiation is built on Palantir infrastructure, but it is not a direct competitor in curated RWD.
• Cytel (Stratos / Lexidy): Cytel is a biostatistics and clinical analytics firm that is both an OneMedNet strategic collaborator and a partial competitor through its real-world and synthetic control arm data services. It is relevant as an existing OneMedNet customer and as a comparable go-to-market for biostatistics services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/OneMedNet
• LinkedInlinkedin.com/company/onemednet-corporation
• Facebookfacebook.com/183550085016503

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds13 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OneMedNet